Particle-mediated intravascular delivery of oligonucleotides to tumors: Associated biology and lessons from genotherapy

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 8, Issue 4, 2001, Pages 191-213

  Dass, Crispin R ^a   Su, Tao ^b  

^a JOHNSON AND JOHNSON   (United States)

^b ST GEORGE HOSPITAL   (Australia)

Author keywords

Cancer; Endothelial cell; Gene therapy; Particle; Polymer

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; DENDRIMER; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; DRUG; DRUG CARRIER; LIPID; LIPOSOME; MICROSPHERE; NANOPARTICLE; NUCLEIC ACID; OLIGONUCLEOTIDE; PACLITAXEL; POLYETHYLENEIMINE; POLYMER; POLYSACCHARIDE; PROTEIN;

ARTICLE; CELL FUNCTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG TARGETING; ENDOTHELIUM CELL; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HUMAN; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PERMEABILITY; PRIORITY JOURNAL; REGULATORY MECHANISM; TUMOR; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM;

ANIMALS; BIOLOGICAL TRANSPORT; CAPILLARY PERMEABILITY; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ENDOTHELIUM, VASCULAR; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; LIPOSOMES; MICROSPHERES; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; OLIGONUCLEOTIDES;

EID: 0035192583     PISSN: 10717544     EISSN: None     Source Type: Journal    
DOI: 10.1080/107175401317245886     Document Type: Article

References (309)

1. The blood supply of experimental liver mestastases. IV. Changes in vascularity with increasing tumour growth
2. The blood supply of experimental liver metastases. I. The distribution of hepatic artery and portal vein blood to small and large tumour
3. Growth regulation of the vascular system: Evidence for a metabolic hypothesis
4. Biodegradable alginate microspheres as a delivery system for naked DNA
5. Combined effects of hepatic arterial embolization using degradable starch microspheres (DSM) in hyperthermia for liver cancer
6. Permeability characteristics of cultured endothelial cell monolayers
7. Microencapsulation of DNA within alginate microspheres and cross-linked chitosan membranes for in viva application
8. Vascular reactions of normal and malignant tissues in vivo. I. Vascular reactions of mice to wounds and to normal and neoplastic transplants
9. Targeted gene delivery: A two-pronged approach
10. Optimization of cationic lipid/DNA complexes for systemic gene transfer to tumor lesions
11. Cationic lipid-based delivery system for systemic cancer gene therapy
12. Spongelike alginate nanoparticles as a new potential system for the delivery of antisense oligonucleotides
13. Control of tumour vasculature permeability
14. Tumour vasculature: A potential therapeutic target
15. Evidence for three-dimensional interlayer correlations in cationic lipid-DNA complexes as observed by cryo-electron microscopy
16. Development of microspheres for neurological dosorders: From basics to clinical applications
17. Gene transfer in vitro and in vivo by cationic lipids is not significantly affected by levels of supercoiling of a reporter plasmid
18. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms
19. Use of liposomes, viral capsids, and nanoparticles as DNA carriers
20. Highly loaded nanoparticle carrier using an hydrophobic antisense oligonucleotide complex
21. Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PA-MAM dendrimers
22. Localized direct plasmid gene delivery in vivo: Prolonged therapy results in reproducible tissue regeneration
23. Tumor angiogenesis and interstitial hypertension
24. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine
25. Brain microvessel endothelial cells in tissue culture: A model for study of blood-brain barrier permeability
26. MCF7 mammary cancer cells respond to bFGF and internalize it following its release from the extracellular matrix: A permissive role for cathepsin D
27. 2+ and von Willebrand factor release in human endothelial cells
28. Potential use of albumin micriospheres as a drug delivery system. I. Preparation and in vitro release of steroids
29. Eradication of large solid tumors in mice with an immunotoxin directed against tumor vasculature
30. In vitro and in vivo response of doxorubicin ion exchange microspheres to hyperthermia
31. Effect of angiotensin II on blood flow in the transplanted sheep squamous cell carcinoma
32. Manipulation of experimental rat and rabbit liver tumour blood flow with angiotensin II
33. Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: An in vivo study relevant to bone marrow purging
34. Influence of formulation parameters on the characteristics of poly(D, L-lactid-coglycolide) microspheres containing poly(L-lysine) complexed plasmid DNA
35. Angiogenesis in cancer and other diseases
36. The combination of degradable starch microspheres and angiotensin II in the manipulation of drug delivery in an animal model of colorectal metastases
37. Increasing hepatic arterial flow to hypovascular hepatic tumours using degradable starch microspheres
38. Liver-directed gene transfer: A linear polyethyleneimine derivative mediates highly efficient DNA delivery to primary hepatocytes in vitro and in vivo
39. Preparation of ethylcellulose capsules containing theophylline by using emulsion non-solvent addition method
40. Characterization of PLGA microspheres for the controlled delivery of IL-1α for tumor immunotherapy
41. Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice
42. Co-polymer of histidine and lysine markedly enhances transfection efficiency of liposomes
43. Pharmaceutical and methodological aspects of microparticles
44. Treatment of patients with irresectable liver metastases from colorectal cancer by chemo-occlusion with degradable starch microspheres
45. Redistribution of arterial blood flow in metastases-bearing livers after infusion of degradable starch microspheres
46. Changes in vascularity of liver tumours after hepatic arterial embolization with degradable starch microspheres
47. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis
48. Inhibition of smooth muscle cell growth in vitro by an antisense oligodeoxynucleotide released from poly(DL-lactic-coglycolic acid) microparticles
49. A comparative study of the anticancer efficacy of doxorubicin carrying microspheres and liposomes using a rat liver tumour model
50. Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles
51. In vivo delivery to tumors of DNA complexed with linear polyethyleneimine
52. Use of endothelial cells containing superparamagnetic microspheres to improve endothelial cell delivery to arterial surfaces after angioplasty
53. Gelatin microspheres as a new approach for the controlled delivery of synthetic oligonucleotides and PCR-generated DNA fragments
54. Inclusion of cholesterol in DOTAP transfection complexes increases the delivery of DNA to cells in vitro in the presence of serum
55. Mechanisms of endothelial growth control
56. The structure of DNA complexes with cationic liposomes - Cylindrical or flat bilayers?
57. Lipoplexes and tumours
58. Microsphere-mediated targeted gene therapy of solid tumours
59. Apolipoprotein A-I, cyclodextrins and liposomes as potential drugs for the reversal of atherosclerosis
60. Delivery of lipoplexes for genotherapy of solid tumours: Role of vascular endothelial cells
61. Barriers to liposomal gene transfer into solid tumours
62. Tumour gene-targeting using microspheres: Cell culture and in vivo studies
63. Tumour vasculature - Summary of recent findings and therapeutic implications
64. Enhanced anticancer therapy mediated by specialised liposomes
65. In vitro evaluation of ionexchange microspheres as carriers of plasmid DNA
66. A microsphere-lipoplex (microplex) vector for targeted gene therapy of cancer. I. Construction and in vitro evaluation
67. A microsphere-lipoplex (microplex) vector for targeted gene therapy of cancer. II. In vivo biodistribution study in a solid tumour model
68. The basis for somatic gene therapy of cancer
69. Antisense RNA to elF4E suppresses oncogenic properties of a head and neck squamous cell carcinoma cell line
70. An easier, reproducible, and mass-production method to study the blood-brain barrier in vitro
71. Endothelial adherens junctions: Implications in the control of vascular permeability and angiogenesis
72. Endothelial adherens junctions: Implications in the control of vascular permeability and angiogenesis
73. Characterization of complexes of oligonucleotides with polyamidoamine starburst dendrimers and effects on intracellular delivery
74. Vasculature as a target for tumor therapy
75. Tumor physiology and cell kinetics
76. Polyethylenimine but not cationic lipid improves antisense activity of 3′-capped phosphodiester oligonucleotides
77. Reciprocal enhancement of gene transfer by combinatorial adenovirus transduction and plasmid DNA transfection in vitro and in vivo
78. The vesiculo-vacuolar organelle (VVO): A distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation
79. Large porous particles for pulmonary drug delivery
80. Choriocarcinoma: Transfilter stimulation of vasoproliferation in the hamster cheek pouch studied by light and electron microscopy
81. Cationic lipid-mediated gene transfer: Effect of serum on cellular uptake and intracellular fate of lipoployamine/DNA complexes
82. The efficacy of doxorubicin microspheres for hepatic micrometastases in a rat tumour model
83. Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells
84. The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer
85. Effect of co-lipids in enchancing cationic lipid-mediated gene transfer in vitro and in vivo
86. Optimization of cationic lipid-mediated gene transfer to airway epithelia
87. Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides
88. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations
89. Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain carrier
90. Role of vascular endothelial growth factor in the regulation of angiogenesis
91. Tumor necrosis factor alpha-induced vascular leakage involves PECAM 1 phosphorylation
92. Orthotopic implantation of human colon carcinoma into nude mice provides a valuable model for the biology and therapy of metastasis
93. The implications of angiogenesis for the biology and therapy of cancer metastases
94. Chemotherapeutic drugs - More really is not better
95. Tumor angiogenesis: Therapeutic implications
96. What is the evidence that tumors are angiogenesis dependent?
97. The role of angiogenesis in tumor growth
98. Angiogenesis in cancer, vascular, rheumatoid, and other disease
99. Blood vessel formation: What is its molecular basis?
100. Cancer: Looking outside the genome
101. Long-term culture of capillary endothelial cells
102. Cultured endothelial cell monolayers that restrict the transendothelial passage of macromolecules and electrical current
103. Migration of neutrophils across monolayers of cultured microvascular endothelial cells. An in vitro model of leucocyte extravasation
104. Thermosensitive liposomes: Extravasation and release of contents in tumor microvascular networks
105. Regulation of endothelial cell gap formation and barrier dysfunction: Role of myosin light chain phosphorylation
106. Vascular endothelial cell activation and permeability responses to thrombin
107. Astrocytes increase barrier properties and ZO-1 expression in retinal vascular endothelial cells
108. Gene-delivery systems using cationic polymers
109. Angiogenesis as a target for tumor treatment
110. Hypoxia-mediated apoptosis from angiogenesis inhibition underlies tumor control by recombinant interleukin 12
111. Interferon-α 2b enhances barrier function of bovine retinal microvascular endothelium in vitro
112. Electrical resistance and macromolecular permeability of retinal capillary endothelial cells in vitro
113. TNF-alpha induces endothelial cell F-actin depolymerization, new actin synthesis, and barrier dysfunction
114. The growth of malignant disease in man and the lower animals with special reference to the vascular system
115. Thrombin
116. Rapid crossing of the pulmonary endothelial barrier by polyethlenimine/DNA complexes
117. Polyethyleneimine-based intravenous delivery of transgenes to mouse lung
118. Selective internal radiation (SIR) therapy for treatment of liver metastases: Measurement of response rates
119. Tumor angiogenesis: Transfilter diffusion studies in the hamster by the transparent chamber technique
120. Astrocytes, cerebral endothelium, and cell culture. The pursuit of an in vitro blood-brain barrier
121. Angiogenesis and oncogenesis
122. Direct observations on the behaviour of microspheres in microvasculature
123. Antisense oligodeoxynucleotide strategies in renal and cardiovascular disease
124. Characterization of the ATPase activity of the 170- to 180-kilodalton membrane glycoprotein associated with multidrug resistance: The 170- to 180-kildalton membrane glycoprotein is an ATPase
125. Separable growth and migration factors for large-cell lymphoma cells secreted by microvascular endothelial cells derived from target organs for metastases
126. Highly efficient suicide gene expression in hepatocellular carcinoma cells by Epstein-Barr virus-based plasmid vectors combined with polyamidoamine dendrimer
127. + hematopoietic cells
128. Openings between dfective endothelial cells explain tumor vessel leakiness
129. Solid stress inhibits the growth of multicellular tumor spheroids
130. Pharmacological manipulation of liver blood flow and its implications for the treatment of hepatic metastases
131. The effects of intra-arterial vasoconstrictors on the distribution of a radiolabelled low molecule weight marker in an experimental model of liver tumor
132. Exposure to free fatty acid increases the transfer of albumin across cultured endothelial monolayers
133. Microvessel density in unknown primary tumors
134. Hydration of lipoplexes commonly used in gene delivery: Follow-up by laurdan fluorescence changes and quantification by differential scanning calorimetry
135. Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
136. New model of tumor angiogenesis: Dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF
137. Angiogenin promotes invasiveness of cultured endothelial cells by stimulation of cell-associated proteolytic activities
138. Liposomal gene delivery: A complex package
139. Development biology of the vascular smooth muscle cell: Building a multilayered vessel wall
140. Vascularization of the Brown-Pearce rabbit epithelioma transplant as seen in the transparent ear chamber
141. Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma
142. A lipid carrier with a membrane active component and a small complex size are required for efficient cellular delivery of antisense phosphorothioate oligonucleotides
143. Nitric oxide synthase inhibition by N(G)-nitro-L-arginine methyl ester inhibits tumor-induced angiogenesis in mammary tumors
144. Transport of molecules across tumor vasculature
145. Transport of molecules in the tumor interstitium: A review
146. Vascular and interstitial barriers to delivery of therapeutic agents in tumors
147. Barriers to drug delivery to solid tumors
148. 1995 Whitaker Lecture: Delivery of molecules, particles, and cells to solid tumors
149. In vitro release of cytotoxic agents from ion exchange resins
150. In vivo microscopy of hepatic tumors in animal models: A dynamic investigation of blood supply to hepatic metastases
151. Phosphate-enhanced transfection of cationic lipid-complexed mRNA and plasmid DNA
152. Atomic force microscopy for studying gene transfection mediated by cationic liposomes and with a cationic cholesterol derivative
153. Effects of polyethyleneimine on endocytosis and lysosome stability
154. A nonviral DNA delivery system based on surface modified silica-nanoparticles can efficiently transfect cells in vitro
155. TNF modulates endothelial properties by decreasing cAMP
156. Pathways of macromolecular tracer transport across venules and small veins. Structural basis for the hyperpermeability of tumor blood vessels
157. Hyperthermia enables tumor-specific nanoparticle delivery: Effect of particle size
158. Signaling angiogenesis and lymphangiogenesis
159. In vivo site-directed mutagenesis of the factor IX gene by chimeric RNA/DNA oligonucleotides
160. Liposomes and nanoparticles as vehicles for antibodies
161. Preparation and in vitro evaluation of streptomycin loaded albumin microspheres for lung targeting
162. Effects of preparation conditions of cisplatin-loaded microspheres on the in vitro release
163. 2+ channel structure and function with antisense oligonucleotides
164. Interendothelial junctions: Structure, signalling and functional roles
165. Gene transfer into subcultured endometrial cells using lipofection
166. Liposomes and lipidic particles in gene therapy
167. Paclitaxel (Taxol): An inhibitor of angiogenesis in a highly vascularized transgenic breast cancer
168. Uptake and intracellular fate of polyethylenemine in vivo
169. In vivo characterization of sustained-release formulations of human growth hormone
170. DNA-polycation nanospheres as non-viral gene delivery vehicles
171. Absence of functional lymphatics within murine sarcoma: A molecular and functional evaluation
172. Development of a sustained-release biodegradable polymer delivery system for site-specific delivery of oligonucleotides: Characterization of P(LA-GA) copolymer microspheres in vitro
173. The significance of heterogeneous tumor cell clumps in the metastatic process
174. Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes
175. Role of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM1-containing liposomes
176. Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration
177. Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery
178. Systemic gene delivery expands the repertoire of effective antiangiogenic agents
179. Fibrin contact increases endothelial permeability to albumin
180. Tissue distribution and persistence in mice of plasmid DNA encapsulated in a PLGA-based microsphere delivery vehicle
181. An in vitro release kinetic examination and comparative evaluation between sub-micron emulsion and polylactic acid nanocapsules of clofibride
182. Thrombin-mediated increase in vascular endothelial permeability
183. Vascular endothelial adhesion molecules and tissue inflammation
184. Endothelial barrier function
185. 125I-labelled polyamidoamine dendrimers in vivo
186. Intraarterial yttrium 90 in the treatment of hepatic malignancy
187. Cytokine regulation of endothelial cell function
188. Biologically erodable microspheres as potential oral drug delivery systems
189. Expression of vascular endothelial growth factor (VEGF) and its receptors in human neuroblastoma
190. Dormancy and breast cancer
191. Drug targeting into the central nervous system by stereotactic implantation of biodegradable microspheres
192. Fibrinogen microspheres as novel drug delivery systems for antitumor drugs
193. Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor
194. Signal transduction and regulation of lung endothelial cell permeability. Interaction between calcium and cAMP
195. Fibrinogen structure and fibrin clot assembly
196. Targeting solid tumours: Challenges, disappointments, and opportunities
197. Protein kinase C beta 1 overexpression augments phorbol ester-induced increase in endothelial permeability
198. Uptake and gene expression of naked plasmid DNA in cultured brain microvessel endothelial cells
199. Heterogeneous induction of apoptosis in colon cancer cells by wild-type p53 gene transfection
200. Preparation, characterisation and in vitro stability of hydrophilic gelatin microspheres using a gelatin methotrexate conjugate
201. Biodegradable microspheres using two different gelatin drug conjugates for the controlled delivery of methotrexate
202. Solid tumour chemotherapy using injectable gelatin microspheres containing free methotrexate and conjugated methotrexate
203. Rabbit beta-migrating very low density lipoprotein increases endothelial macromolecular transport without altering electrical resistance
204. A new temperature sensitive liposome for use with mild hyperthermia: Characterization and testing in a human tumor xenograft model
205. Role of the extracellular matrix assembly in interstitial transport in solid tumours
206. The biology of PECAM-1
207. High-efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in vivo electroporation
208. Application of epirubicin containing albumin microspheres in the experimental therapy of breast cancer
209. Hepatic uptake of polystyrene microspheres in rats: Effect of particle size on intrahepatic distribution
210. Antibody-based therapy targeting tumor vascular endothelial cells suppresses solid tumor growth in rats
211. Rapid increase in blood-brain barrier permeability during severe hypoxia and metabolic inhibition
212. 33P]DNA following intravenous administration of DNA/cationic lipid complexes in mice: Use of a novel radionuclide approach
213. Structural aspects of the permeability of the microvascular endothelium
214. Blood-brain barrier carrier-mediated transport and brain metabolism of amino acids
215. Liposome-mediated gene transfer into human vascular smooth muscle cells
216. Vascular morphology and angiogenesis in glial tumors
217. Molecular mechanisms of developmental and tumor angiogenesis
218. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis
219. Activation and injury of endothelial cells by cytokines
220. The pathophysiology of angiogenesis
221. Induction of neovascularization in vivo and endothelial cell proliferation in vitro by tumor-associated macrophages
222. Encapsulation of proteins for improved delivery
223. Enhanced anti-tumor effects with microencapsulated c-myc antisense oligonucleotide
224. Structure of DNA-cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packaging regimes
225. Consequences of angiogenesis for tumor progression, metastases and cancer therapy
226. Hydrolysed microspheres from cross-linked polymethyl methacrylate (hydrogel)
227. Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene
228. Differentiation of endothelium
229. Development of the blood-brain barrier [see comments]
230. Polarity and the development of the outer blood-retinal barrier
231. Pharmocokinetics and metabolism of anthracyclines
232. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor
233. Neovasculature induced by vascular endothelial growth factor is fenestrated
234. Degradable starch microspheres in cytostatic treatment of a liver carcinoma: Experimental studies in rats with 5-fluorouracil, tauromustine, carmustine, doxorubicine and RSU-1069
235. A cell culture model of the blood-brain barrier
236. Interactions of polymeric and liposomal gene delivery systems with extracellular glycosaminoglycans: Physicochemical and transfection studies
237. Direct catheter redirection of a symptomatic errant intracranial silastic sphere embolus
238. In vitro evaluation of the hydrolytic degradation of dispersed and aggregated poly(DL-lactide-co-glycolide) microspheres
239. New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury
240. Multicellular tumour spheroids in radiation biology
241. Encapsulation of plasmid DNA in stabilized plasmid-lipid particles composed of different cationic lipid concentration for optimal transfection activity
242. Targeting vascular endothelial growth factor (VEGF) for anti-tumor therapy, by anti-VEGF neutralizing monoclonal antibodies or by VEGF receptor tyrosine-kinase inhibitors
243. Microvessel organisation and structure in experimental brain tumours: Microvessel populations with distinctive structural and functional properties
244. Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: Formation of novel small multilamellar vesicle structures
245. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
246. DNA delivery from polymer matrices for tissue engineering
247. Role of tyrosine phosphorylation in thrombin-induced endothelial cell contraction and barrier function
248. Molecular sieving characteristics of the cultured endothelial monolayer
249. Endothelial cell response to normal and abnormal stimuli
250. Endothelial transport of macromolecules: Transcytosis and endocytosis
251. Gene therapy: Trials and tribulations
252. Cationic liposome and plasmid DNA complexes formed in the serum-free medium under optimum transfection condition are negatively charged
253. Efficient in vivo gene delivery by the negatively charged complexes of cationic liposomes and plasmid DNA
254. Cell adhesion, cell junctions and the blood-brain barrier
255. Importance of liposome complexing volume in transfection optimization
256. Degradable starch microspheres increase the cytostatic effect of the bioreductive drug RSU-1069 (aziridine 2-nitroimidazole) at arterial administration in rats with a liver carcinoma
257. Tumor cell interactions with the extracellular matrix during invasion and metastases
258. Oncotic pressure in solid tumors is elevated
259. A novel, long-circulating, and functional liposomal formulation of antisense oligodeoxynucleotides targeted against MDR1
260. Macrophages and angiogenesis
261. Chemo-occlusion for the treatment of liver cancer. A new technique using degradable starch microspheres
262. Growth factors in the extracellular matrix
263. Involvement of specific mechanism in plasmid DNA uptake by mouse peritoneal macrophages
264. Transfection of human endothelial cells
265. Antibody-directed targeting of the vasculature of solid tumors
266. Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice
267. Natural killer cells: Endothelial interactions, migration, and target cell recognition
268. Formulation of poly(D, L-lactic-co-glycolic acid) microparticles for rapid plasmid DNA delivery
269. Starburst dendrimers: Molecularlevel control of size, shape, surface chemistry, topology and flexibility from atoms to macroscopic matter
270. Microvessel quantification and its possible relation with liver metastasis in colorectal cancer
271. Highly efficient cellular uptake of c-myb antisense oligonucleotides through specifically designed polymeric nanospheres
272. Controlled gene delivery by DNA-gelatin nanospheres
273. Multidrug resistance
274. Formulations which increase the size of lipoplexes prevent serum-aasociated inhibition of transfection
275. Effect of exogenous angiotensin-II on local blood flow in kidneys with neoplasm
276. Effects of vasopressin, noradrenalin, and oxytocin on blood flow distribution in rat kidney with neoplasm
277. The role of stromal cells in tumor metastasis: A new link
278. Endothelial permeability for macromolecules. Mechanistic aspects of pathophysiological modulation
279. Role of Ca2+/calmodulin-dependent phosphatase 2B in thrombin-induced endothelial cell contractile responses
280. Self-assembly of polyamine-poly(ethylene glycol) copolymers with phosphorothioate oligonucleotides
281. A multi-step lipid mixing assay to model structural changes in cationic lipoplexes used for in vitro transfection
282. Detection and quantification of vascular endothelial growth factor/vascular permeability factor in brain tumor tissue and cyst fluid: The key to angiogenesis?
283. Phase I and clinical pharmacology study of intravenous flavone acetic acid (NSC 347512)
284. A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung
285. Abnormal vasculature of solid tumors: Significance for microsphere-based targeting strategies
286. Perspective on microspheres in regional cancer therapy
287. Cationic lipid binding to DNA: Characterization of complex formation
288. Polycation liposomes, a novel nonviral gene transfer system, constructed from cetylated polyethyleneimine
289. Vascular-specific growth factors and blood vessel formation
290. Vasculogenesis, angiogenesis, and growth factors: Ephrins enter the fray at the border
291. Percutaneous internal maxillary arterial embolization with ethylcellulose microspheres
292. Time-dependent maturation of cationic liposome-DNA complex for serum resistance
293. PAMAM dendrimers as delivery agents for antisense oligonucleotides
294. Vascular permeability in a human tumor xenograft: Molecular size-dependence and cut-off size
295. Cellular and molecular barriers to gene transfer by a cationic lipid
296. A model for dose estimation in therapy of liver with intraarterial microspheres
297. Oligonucleotide uptake in human hematopoietic cells is increased in leukemia and is related to cellular activation
298. Antisense oligonucleotide delivery with polyhexylcyanoacrylate nanoparticles as carriers
299. Evaluation of pilocarpine-loaded albumin particles as drug delivery systems for controlled delivery in the eye. I. In vitro and in vivo characterisation
300. Evaluation of aminoalkylmethacrylate nanoparticles as colloidal drug carrier systems. Part II: Characterization of antisense oligonucleotides loaded copolymer nanoparticles
301. Effect of ultrasonication on the stability of oligonucleotides adsorbed on nanoparticles and liposomes
302. Enhanced antisense efficacy of oligonucleotides adsorbed to monomethylaminoethyl-methacrylate methylmethacrylate coolymer nanoparticles
303. Electrostatic and structural properties of complexes involving plasmid DNA and cationic lipids commonly used for gene delivery